Skip to product information
1 of 1

Elabscience

SKU:PKSV030369

Recombinant SARS-CoV-2 Spike RBD(K417N, E484K, N501Y)(His Tag), Biotinylated

Recombinant SARS-CoV-2 Spike RBD(K417N, E484K, N501Y)(His Tag), Biotinylated

Regular price $950.00 USD
Regular price Sale price $950.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant SARS-CoV-2 Spike RBD(K417N, E484K, N501Y)(His Tag), Biotinylated - a highly advanced and innovative product designed to cater to the needs of the scientific community. This product is a result of extensive research and development, and is characterized by its exceptional quality and reliability.

The Recombinant SARS-CoV-2 Spike RBD(K417N, E484K, N501Y)(His Tag), Biotinylated is a biotinylated protein that is designed to bind specifically to the SARS-CoV-2 virus. It is composed of a recombinant spike receptor-binding domain (RBD) that contains three key mutations - K417N, E484K, and N501Y - and is tagged with a histidine (His) tag for easy purification.

This product is highly versatile and can be used in a wide range of applications, including ELISA, SPR, and other binding assays. It is also highly stable and can be stored for long periods of time without losing its activity or functionality.

The Recombinant SARS-CoV-2 Spike RBD(K417N, E484K, N501Y)(His Tag), Biotinylated is an essential tool for researchers and scientists who are working towards understanding the SARS-CoV-2 virus and developing effective treatments and vaccines. Its exceptional quality and reliability make it an indispensable asset in the fight against the COVID-19 pandemic.

In conclusion, the Recombinant SARS-CoV-2 Spike RBD(K417N, E484K, N501Y)(His Tag), Biotinylated is a highly advanced and innovative product that is designed to cater to the needs of the scientific community. Its exceptional quality, reliability, and versatility make it an indispensable tool for researchers and scientists who are working towards understanding the SARS-CoV-2 virus and developing effective treatments and vaccines.
View full details